Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-17

Clinical Trial Update: Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating treatment to reduce vascular calcification in hemodialysis patients using vitamin K has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin K (Vitamin K)

Snippet

Sponsor: National University Health System, Singapore | Conditions: Vascular Calcification, Systemic and Arterial Stiffness | Phase 2 | Status: COMPLETED